搜索结果: 1-15 共查到“肿瘤学 lung”相关记录43条 . 查询时间(0.031 秒)
Data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer（图）
晚期肺癌 免疫治疗 停止治疗
font style='font-size:12px;'>
2023/6/27
Over the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment for patients with advanced lung cancer, helping many live longer lives and improving overall survival fo...
Why lung cancer doesn’t respond well to immunotherapy（图）
肺癌 免疫疗法 淋巴结 T细胞
font style='font-size:12px;'>
2023/6/5
Immunotherapy — drug treatment that stimulates the immune system to attack tumors — works well against some types of cancer, but it has shown mixed success against lung cancer.
Rare molecular subsets among lung tumours–what makes them stand apart from the common?
Rare molecular subsets tumours cancers
font style='font-size:12px;'>
2015/4/21
While there is no universally agreed upon definition, rare malignancies are often defined as those with an incidence of <6 per l00,000 population. However, increasingly, commonly occurring cancers are...
Lung cancer screening: Summary of the evidence and the 2013 US Preventative Services Task Force recommendations
Lung cancer screening Summary of the evidence the 2013 US Preventative Services Task Force
font style='font-size:12px;'>
2015/4/17
The United States Preventative Services Task Force is an independent panel of non-Federal experts in prevention and evidence-based medicine that reviews scientific studies and makes recommendations on...
Lung cancer
Lung cancer surgery
font style='font-size:12px;'>
2015/4/8
Almost untreatable in 1973, except by surgery, lung cancer is now susceptible to radiotherapy and chemotherapy as
well, and is often treated by all three modalities in combination. Although tobacco ...
Evolution of biological therapies in non-small cell lung cancer
biological therapies non-small cell lung cancer
font style='font-size:12px;'>
2015/3/26
This article explores recent clinical developments of biological or targeted therapies in non-small cell lung cancer. Molecular research has given us a greater understanding of tumour biology and has ...
Non-small cell lung cancer in the elderly - systemic therapy
Non-small cell lung cancer elderly - systemic therapy
font style='font-size:12px;'>
2015/3/26
Elderly patients represent a significant and rising proportion of patients with Non-Small Cell Lung Cancer and historically they have been under-treated and under-represented in clinical trials. Incre...
Brachial plexus surgery and apical lung tumours
Brachial plexus surgery apical lung tumours
font style='font-size:12px;'>
2015/3/17
Historically, management of apical lung tumours (superior sulcus tumours or Pancoast tumours) that involve the brachial plexus has been very limited, and usually all that was offered was palliative ca...
Helical CT screening for lung cancer
Helical CT screening lung cancer
font style='font-size:12px;'>
2015/3/11
A technique which can detect a growing pulmonary malignancy when it is small should allow more effective therapy and a better outcome for patients. Henschke and her colleagues in the Early Lung Cancer...
FDG PET: Revolution or evolution in the management of non-small cell lung cancer?
Revolution evolution management of non-small cell lung cancer
font style='font-size:12px;'>
2015/3/11
Lung cancer is currently the leading cause of cancer-related death in both men and women in most Western countries. In Australia there is a falling incidence in males that is not matched in females, t...
Contemporary management of non-small cell lung cancer in Australia
Contemporary management non-small cell lung cancer Australia
font style='font-size:12px;'>
2015/3/11
In 1955, Bromley and Szur reported on 66 patients with a pathologic diagnosis of lung cancer who had been treated with high dose radiotherapy and who had then proceeded to surgery1. In 24 (46.7%) no t...
Systemic therapy of lung cancer: where are we in 2002?
Systemic therapy lung cancer where are we in 2002
font style='font-size:12px;'>
2015/3/11
At a time when our understanding of the molecular biology of cancer was supposed to lead to major advances in therapy, it is disappointing to report that the major lung cancer ‘story’ of 2002 (table o...
The thoracic physician and lung cancer in 2003
The thoracic physician lung cancer 2003
font style='font-size:12px;'>
2015/3/11
As the biggest cause of cancer death in the Western world, lung cancer is frequently encountered in the day-to-day practice of adult thoracic physicians. The vast explosion of knowledge, ranging from ...
Researchers discover new genetic anomalies in lung cancer（图）
new genetic anomalies lung cancer
font style='font-size:12px;'>
2014/12/30
By analyzing the DNA and RNA of lung cancers, researchers at the University of Michigan Comprehensive Cancer Center found that patients whose tumors contained a large number of gene fusions had worse ...
Sleep Duration and Risk of Lung Cancer in the Physicians' Health Study
Sleep Duration Risk Lung Cancer Physicians' Health Study
font style='font-size:12px;'>
2014/9/29
Background and Objectives: Lung cancer is the most common cancer and cancer related cause of death worldwide. However, the association between sleep duration and incident lung cancer has not been inve...